Skip to content

All recalls FDA

FDADrugsRecalled Status: Ongoing

Hikma Pharmaceuticals USA INC. recalls Ramipril Capsules USP

Class IIofficial

FDA Class II

FDA classified this recall as Class II: the product may cause health problems that are temporary or can be treated; the chance of serious harm is remote.

Hazard
Failed Impurities/Degradation Specifications: OOS result obtained for a process impurity, dicyclohexylurea (DCU).
Products
  • Ramipril Capsules USP
Where it was sold

Nationwide within the United States

Nationwide

Units affected
a) 25,970 bottles; b) 2,384 bottles
About this recall
Ramipril Capsules USP, 10 mg, packaged in a) 100 Capsules (NDC 76282-673-01) and b) 500 Capsules (NDC 76282-673-05) bottles, Rx only, Manufactured for: Exelan Pharmaceuticals, Inc., Boca Raton, FL 33432, Manufactured by: West-Ward Columbus Inc., Columbus, OH 43228.